Selective glomerular hypofiltration syndrome: a novel renal phenotype associated with cardiovascular disease and adverse outcomes in diabetic kidney disease.
文献摘要
Introduction Selective glomerular hypofiltration syndrome (SGHS), defined by a low ratio of estimated glomerular filtration rate using cystatin C (eGFRcys) to estimated glomerular filtration rate using creatinine (eGFRcr), has emerged as a novel kidney dysfunction phenotype. Its role in diabetic kidney disease (DKD) remains unknown. This study aimed to investigate the association between SGHS and the prevalence of cardiovascular disease (CVD) at the time of renal biopsy-diagnosed DKD, as well as its association with long-term renal outcomes. Research design and methods This study included 182 patients with biopsy-proven DKD. SGHS was defined as eGFRcys/eGFRcr ratio Results Of 182 patients, 41 (22.5%) had SGHS. The eGFRcys/eGFRcr ratio better predicted CVD (area under the curve (AUC) 0.730, 95% CI 0.643 to 0.816) than eGFRcr (AUC 0.602, 95% CI 0.507 to 0.697), eGFRcys (AUC 0.701, 95% CI 0.615 to 0.786), estimated glomerular filtration rate based on creatinine and cystatin C (AUC 0.685, 95% CI 0.595 to 0.774), and urinary albumin-to-creatinine ratio (AUC 0.633, 95% CI 0.540 to 0.725). SGHS was independently associated with CVD after adjustment (OR 9.27, 95% CI 3.20 to 26.84; p Conclusions SGHS is independently associated with the prevalence of CVD at the time of DKD diagnosis, and independently predicts adverse renal outcomes in patients with DKD. As an easily obtainable parameter, the eGFRcys/eGFRcr ratio may serve as a valuable risk assessment tool in patients with DKD.